PCRX logo

Pacira BioSciences, Inc. (PCRX) Retained Earnings

Annual Retained Earnings:

-$206.36M-$99.56M(-93.22%)
December 31, 2024

Summary

  • As of today, PCRX annual retained earnings is -$206.36 million, with the most recent change of -$99.56 million (-93.22%) on December 31, 2024.
  • During the last 3 years, PCRX annual retained earnings has risen by +$5.54 million (+2.61%).
  • PCRX annual retained earnings is now -164.37% below its all-time high of -$78.06 million, reached on December 31, 2008.

Performance

PCRX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCRXbalance sheet metrics

Quarterly Retained Earnings:

-$206.39M-$4.85M(-2.40%)
June 30, 2025

Summary

  • As of today, PCRX quarterly retained earnings is -$206.39 million, with the most recent change of -$4.85 million (-2.40%) on June 30, 2025.
  • Over the past year, PCRX quarterly retained earnings has dropped by -$127.46 million (-161.48%).
  • PCRX quarterly retained earnings is now -161.48% below its all-time high of -$78.93 million, reached on June 30, 2024.

Performance

PCRX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCRXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

PCRX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-93.2%-161.5%
3Y3 Years+2.6%-49.6%
5Y5 Years+48.3%+48.2%

PCRX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-93.2%+2.6%-161.5%+7.2%
5Y5-Year-93.2%+48.3%-161.5%+23.1%
All-TimeAll-Time-164.4%+48.3%-161.5%+48.3%

PCRX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$206.39M(-2.4%)
Mar 2025
-
-$201.54M(+2.3%)
Dec 2024
-$206.36M(-93.2%)
-$206.36M(+7.2%)
Sep 2024
-
-$222.40M(-181.8%)
Jun 2024
-
-$78.93M(+19.3%)
Mar 2024
-
-$97.82M(+8.4%)
Dec 2023
-$106.80M(+28.2%)
-$106.80M(+18.9%)
Sep 2023
-
-$131.67M(+7.6%)
Jun 2023
-
-$142.52M(+15.3%)
Mar 2023
-
-$168.29M(-13.1%)
Dec 2022
-$148.75M(+29.8%)
-$148.75M(-7.3%)
Sep 2022
-
-$138.65M(-0.5%)
Jun 2022
-
-$137.96M(+12.6%)
Mar 2022
-
-$157.83M(+25.5%)
Dec 2021
-$211.90M(+16.5%)
-$211.90M(-2.5%)
Sep 2021
-
-$206.76M(+7.9%)
Jun 2021
-
-$224.43M(+7.8%)
Mar 2021
-
-$243.51M(+4.1%)
Dec 2020
-$253.88M(+36.4%)
-$253.88M(+5.4%)
Sep 2020
-
-$268.39M(+32.7%)
Jun 2020
-
-$398.51M(-1.9%)
Mar 2020
-
-$391.24M(+2.0%)
Dec 2019
-$399.40M(-2.9%)
-$399.40M(-1.2%)
Sep 2019
-
-$394.51M(-1.6%)
Jun 2019
-
-$388.42M(+0.7%)
Mar 2019
-
-$391.15M(-0.8%)
Dec 2018
-$388.23M(+0.2%)
-$388.23M(+2.1%)
Sep 2018
-
-$396.51M(-0.2%)
Jun 2018
-
-$395.87M(+0.6%)
Mar 2018
-
-$398.45M(-2.4%)
Dec 2017
-$389.14M
-$389.14M(+1.2%)
DateAnnualQuarterly
Sep 2017
-
-$393.73M(-2.0%)
Jun 2017
-
-$386.13M(-5.4%)
Mar 2017
-
-$366.39M(-5.8%)
Dec 2016
-$346.24M(-12.3%)
-$346.24M(-1.2%)
Sep 2016
-
-$342.27M(-6.9%)
Jun 2016
-
-$320.10M(-2.5%)
Mar 2016
-
-$312.14M(-2.1%)
Dec 2015
-$308.29M(+0.6%)
-
Sep 2015
-
-$305.79M(+1.0%)
Jun 2015
-
-$308.88M(+0.0%)
Mar 2015
-
-$308.88M(+0.4%)
Dec 2014
-$310.14M(-4.6%)
-$310.14M(+1.8%)
Sep 2014
-
-$315.95M(-1.0%)
Jun 2014
-
-$312.94M(-1.6%)
Mar 2014
-
-$307.91M(-3.9%)
Dec 2013
-$296.43M(-27.5%)
-$296.43M(-4.2%)
Sep 2013
-
-$284.47M(-5.5%)
Jun 2013
-
-$269.69M(-5.5%)
Mar 2013
-
-$255.66M(-10.0%)
Dec 2012
-$232.52M(-29.0%)
-$232.52M(-7.6%)
Sep 2012
-
-$216.17M(-7.9%)
Jun 2012
-
-$200.43M(-4.3%)
Mar 2012
-
-$192.13M(-6.6%)
Dec 2011
-$180.24M(-31.6%)
-$180.24M(-9.3%)
Sep 2011
-
-$164.96M(-6.1%)
Jun 2011
-
-$155.45M(-6.0%)
Mar 2011
-
-$146.69M(-7.1%)
Dec 2010
-$136.91M(-24.7%)
-$136.91M(-5.4%)
Sep 2010
-
-$129.87M(-7.3%)
Jun 2010
-
-$121.06M(-10.3%)
Dec 2009
-$109.76M(-40.6%)
-$109.76M
Dec 2008
-$78.06M
-

FAQ

  • What is Pacira BioSciences, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Pacira BioSciences, Inc.?
  • What is Pacira BioSciences, Inc. annual retained earnings year-on-year change?
  • What is Pacira BioSciences, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Pacira BioSciences, Inc.?
  • What is Pacira BioSciences, Inc. quarterly retained earnings year-on-year change?

What is Pacira BioSciences, Inc. annual retained earnings?

The current annual retained earnings of PCRX is -$206.36M

What is the all-time high annual retained earnings for Pacira BioSciences, Inc.?

Pacira BioSciences, Inc. all-time high annual retained earnings is -$78.06M

What is Pacira BioSciences, Inc. annual retained earnings year-on-year change?

Over the past year, PCRX annual retained earnings has changed by -$99.56M (-93.22%)

What is Pacira BioSciences, Inc. quarterly retained earnings?

The current quarterly retained earnings of PCRX is -$206.39M

What is the all-time high quarterly retained earnings for Pacira BioSciences, Inc.?

Pacira BioSciences, Inc. all-time high quarterly retained earnings is -$78.93M

What is Pacira BioSciences, Inc. quarterly retained earnings year-on-year change?

Over the past year, PCRX quarterly retained earnings has changed by -$127.46M (-161.48%)
On this page